VAERS reports by lot

Moderna COVID-19 lot 039021A: VAERS reports

25 VAERS reports list lot 039021A as a Moderna COVID-19 vaccine, received between 2021-07-15 and 2023-11-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
20%
Marked serious
1
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1721%
Musculoskeletal1519%
Neurological1316%
Respiratory1012%
Gastrointestinal810%
Cardiac / Cardiovascular79%
Dermatological (non-injection-site)34%
Thrombotic / Hematological22%
Allergic / Anaphylactic22%
Injection-site / Local reaction22%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Washington3
Oregon3
California3
Iowa1
Kentucky1
Missouri1
Maryland1
Ohio1
Pennsylvania1
Connecticut1
Georgia1
Delaware1

Reports by month received

2021-071
2021-106
2021-115
2021-122
2022-011
2022-031
2022-045
2022-071
2022-081
2022-111
2023-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.